Submissão de Trabalhos

• Submission Deadline: January 28, 2027, at 9:00 PM BRT (Brazil Time).
• Originality: RETINA 2027 will accept only original scientific papers that remain unpublished up to the presentation date at the Congress.
• Language Requirement: All abstracts must be written exclusively in English. Submissions in any other language will be automatically rejected without peer review.
• Submission Channel: The Scientific Committee accepts online submissions exclusively via the official Congress website e-form. Submissions failing to strictly comply with published BRAVS regulations will be rejected.
• Attendance Requirement: Abstracts must only be submitted if at least one author intends to register for the Congress and present the work in person.

• Account Creation: To access the abstract submission e-form, authors must first complete online registration on the portal.
• Registration & Payment: At least one author must be registered for the Congress to submit an abstract. Immediate payment is not required at the time of submission; authors may log back into their account to finalize payment according to the fee schedule for their category.
• Corresponding Author Information: Full contact details (mailing address, department, institution, and a valid email address) for the corresponding author must be provided. All official communications will be sent exclusively to this email address.
• Membership Status: BRAVS membership is not mandatory for abstract submission.

Every abstract submission must select one presentation format:

Presentation Formats:

• Oral Papers
• Poster

• Submission Limits:
  • Submissions per Author: Unlimited submissions allowed per primary author.
  • Authors per Abstract: Maximum of 8 (eight) authors per paper (1 primary author and up to 7 co-authors).
• Character Limit: Maximum of 1,500 characters (excluding title and author list). The submission system automatically tracks character counts and alerts the author if the limit is exceeded.
• Required Structure: Abstracts must follow a structured format:
  • Purpose
  • Methods
  • Results
  • Conclusion
• Content Restrictions: Tables, graphics, charts, embedded images, and videos are strictly prohibited within the abstract e-form.

• Editing Submissions: Authors may edit, revise, or update their submitted abstracts at any time prior to finalizing the submission. No changes of any kind will be permitted after submission.
• No Post-Deadline Alterations: Under no circumstances will the Scientific Committee or Executive Secretariat perform corrections, text substitutions, or structural changes to submitted abstracts.

• Publishing Rights: By submitting an abstract, authors grant the Organizing Committee and BRAVS full authorization to publish, distribute, and archive the work nationally and internationally across all print, digital, and electronic media without royalty obligations or financial compensation.
• Digital Library Access: All accepted abstracts will be archived and accessible via the official RETINA 2027 website and the BRAVS Digital Library from mid-May 2027 through April 2028.
• Copyright & Patient Privacy: Authors must ensure full compliance with copyright laws and guarantee patient anonymity in all displayed clinical photographs, diagnostic images, and graphics.